Synthesis and antiviral activity of L-2'-deoxy-2'-up-fluoro-4'-thionucleosides. 1999

L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
College of Pharmacy, Ewha Womans University, Seoul, Korea.

L-2'-Deoxy-2'-up-fluoro-4'-thionucleosides were efficiently synthesized from D-xylose via L-4-thioarabitol derivative as a key intermediate and evaluated for antiviral activities against HIV-1, HSV-1,2 and HBV.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013872 Thionucleosides Nucleosides in which the base moiety is substituted with one or more sulfur atoms.
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D018258 Herpesvirus 2, Human A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact. HSV-2,Herpes Simplex Virus 2,Human Herpesvirus 2,HHV-2,Herpes Simplex Virus Type 2,Herpesvirus 2 (alpha), Human
D018259 Herpesvirus 1, Human The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions. HSV-1,Herpes Simplex Virus 1,HHV-1,Herpes Simplex Virus Type 1,Herpesvirus 1 (alpha), Human,Human Herpesvirus 1

Related Publications

L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
April 2022, Bioorganic & medicinal chemistry letters,
L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
October 2002, Journal of medicinal chemistry,
L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
December 2006, Organic letters,
L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
January 2010, Organic & biomolecular chemistry,
L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
March 1999, Nucleosides & nucleotides,
L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
January 2003, Journal of medicinal chemistry,
L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
December 1996, Chemical & pharmaceutical bulletin,
L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
March 2020, Molecules (Basel, Switzerland),
L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
February 2008, Journal of enzyme inhibition and medicinal chemistry,
L S Jeong, and H R Moon, and S J Yoo, and S N Lee, and H D Kim, and M W Chun
January 1996, Journal of medicinal chemistry,
Copied contents to your clipboard!